beta adrenoceptor blockers
To date, only       beta adrenoceptor blockers have been shown to improve survival in post-MI       patients as well as in patients with cardiomyopathy and CHF.
To date, only        @SUBJECT$  have been shown to improve survival  @PREDICAT$  post- @OBJECT$        patients as well as in patients with cardiomyopathy and CHF.